Anticholinergic premedication for infants and children (The oculocardiac reflex)
To the Editor: We recognize that the general issue of anticholinergic premedication for infants and children remains controversial, but suggest that Steward's editoriall in response to our article examining the oculocardiac reflex 2 is not a complete examination of the issue. We are also concerned that the editorial failed to stress the real problem we were emphasizing, the need for better understanding of the oculocardiac reflex (OCR).
Donlon, in a current and popular textbook of anaesthesia 3 reminds us that the use of atropine for the prevention of the OCR remains controversial. In his own text, Smith 4 examines the controversy, and notes that Katz & Bigger of the Columbia Presbyterian Medical Center concluded with respect to the surgical correction of strabismus (page 484): "Both intravenous atropine and retrobulbar block were abandoned, and the current practice at Columbia is to monitor ECG and if a persistent arrhythmia develops, the surgeon temporarily stops manipulation. This method has been safely employed with over 2,000 patients during the past 6 years." On the other hand, Smith also notes that Taylor et al. reported that none of the methods described to prevent the OCR had been found to be as effective as intravenous atropine administered within 30 minutes before surgery. Smith also notes (page 485) that "one should avoid the administration of atropine while the vagal reflex is still active, or one should expect to encounter some very bizarre cardiac tracings." Steward himself recommendsS: "if brachycardia occurs (in spite of a previous dose of O. 02 rag. kg -i of atropine i.v.) , ask the surgeon to discontinue manipulation until you have given a further dose of atropine i.v." Application of this recommendation leads to the administration of a total dose of 0.04 mg-kg-1 of atropine i.v., in an infant or child with an active vagal reflex, during halothane anaesthesia and spontaneous ventilation. We question whether this is the best advice in this clinical situation.
Steward's editorial comments that intravenous atropine can safely and effectively block the OCR 1 appear to be at least in partial contradiction to the above comment that more than one dose of intravenous atropine may be necessary. Further, the fact that the OCR tends to fatigue, as graphically demonstrated in our study, 2 did not receive adequate emphasis in Steward's editorial.
In our practice we do not hesitate to administer intravenous atropine (0.01 mg,kg-t) or glycopyrrolate (0.005mg.kg -I) when indicated, as for example in non-premedicated infants and children, in outpatient surgery, prior to intravenous succinylcholine, in oropharyngeal surgery, etc. However, we feel strongly that one should not rely on intravenous atropine to prevent the OCR in the absence of close co-operation between the surgeon and the anaesthetist. Without such close co-operation, we feel that any form of anaesthetic management may prove unacceptable.
We suggest that anticholinergics do not compensate for aggressive and non-physiological manipulation of the extraocular muscles. In such circumstances atropine does not block the OCR but rather may transform severe bradycardia (or sino-atrial arrest) into a serious ventrieular arrhythmia.
Finally, regardless of the issue of use of anticholinergics and their route of administration, we encourage all who participate in these operations to be fully aware of the factors producing or potentiating the OCR. We hope that Steward will consider inclusion in the next edition of his textbook the comment: "Practise controlled ventilation, at least immediately before and during the extraocular muscle traction."
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